Skip to Main Content

Paper Details

Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial.
Ann Oncol
22
2022
Author NameAffiliation
Alan Dal PraUniversity of Miami Miller School of Medicine, Bern University Hospital, University of Bern
Elai DavicioniDecipher Biosciences (a subsidiary of Veracyte Inc.)
Alan PollackUniversity of Miami Miller School of Medicine
  • 1 - 3

Datasets

Release 1.2